Rda Financial Network Bristol Myers Squibb CO Transaction History

Rda Financial Network

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$72.62 - $79.98 $189,756 - $208,987	2,613 New	2,613 $201,000
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $279,288 - $316,484	-4,837 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$57.43 - $63.64 $40,028 - $44,357	697 Added 16.84%	4,837 $292,000
Q2 2020 Jul 14, 2020	BUY	$54.82 - $64.09 $226,954 - $265,332	4,140 New	4,140 $243,000
Q1 2020 Apr 06, 2020	SELL	$46.4 - $67.43 $205,784 - $299,052	-4,435 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$49.21 - $64.19 $218,246 - $284,682	4,435 New	4,435 $284,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Rda Financial Network, based on Form 13F filings with the SEC.

Stay updated on Rda Financial Network with notifications on news.